Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 1, 1999British Journal of PharmacologyOpen Access

Effect of cerivastatin sodium, a new inhibitor of HMG‐CoA reductase, on plasma lipid levels, progression of atherosclerosis, and the lesional composition in the plaques of WHHL rabbits

View Full Paper
Ask AI
Bookmark
Share

Authors

MSMasashi ShiomiKobe UniversityTITakashi ItoKyushu University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Shiomi et al. (1999) studied this question.

synapsesocial.com/papers/6a152e355347fbb1739f5ba3https://doi.org/10.1038/sj.bjp.0702382
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content.1993 · 1,134 citations
  2. 2Macrophage foam cells from experimental atheroma constitutively produce matrix-degrading proteinases.1995 · 557 citations
  3. 3Reduction of Serum Cholesterol Levels Alters Lesional Composition of Atherosclerotic Plaques1995 · 128 citations
  4. 4Primary Prevention of Acute Coronary Events With Lovastatin in Men and Women With Average Cholesterol Levels1998 · 5,296 citations